TCM Biotech International Corp. (TPE:4169)

TCM Biotech International Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	703.09	685.49	666.53	969.62	802.42	702.05
Revenue Growth	7.04%	2.84%	-31.26%	20.84%	14.30%	-4.75%
Gross Profit Gross Profit Growth	318.2	316.99	327.31	480.17	448.49	358.72
Operating Income Operating Income Growth	-15.76	18.65	10.7	22.33	25.3	2.13
Net Income Net Income Growth	-13.8	19.17	21.01	18.57	18.27	1.87
Earnings Per Share EPS Growth	-0.24	0.32	0.36	0.35	0.37	0.04
EPS Growth	-	-10.06%	1.66%	-5.41%	861.49%	-92.66%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Department Medicine Department Medicine Growth	646.63	627.77	609.04	905.78	721.03	637.09
Functional Food Functional Food Growth	56.35	57.61	56.88	63.35	62.37	64.96
Other Department Other Department Growth	-	0.11	0.62	0.49	19.02	-
Total Total Growth	703.09	685.49	666.53	969.62	802.42	702.05

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	592.57	545.07	532.98	504.13	89.94	58.26
Total Debt Total Debt Growth	17.88	37.2	43.46	115.38	157.46	161
Net Cash (Debt) Net Cash Growth	574.69	507.87	489.52	388.76	-67.52	-102.75
Net Cash Growth	17.40%	3.75%	25.92%	-	-	-
Net Cash Per Share Net Cash Per Share Growth	9.73	8.60	8.29	7.33	-1.38	-2.11

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	28.9	37.13	167.42	-37.54	52.24	15.33
Capital Expenditures CapEx Growth	-2.08	-2.49	-8	-3.98	-3.78	-4.14
Free Cash Flow Free Cash Flow Growth	26.81	34.65	159.42	-41.51	48.46	11.19
Free Cash Flow Growth	-78.24%	-78.27%	-	-	333.15%	-84.45%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	45.26%	46.24%	49.11%	49.52%	55.89%	51.10%
Operating Margin	-2.24%	2.72%	1.60%	2.30%	3.15%	0.30%
Pretax Margin	-1.73%	3.25%	3.75%	2.27%	2.88%	0.32%
Profit Margin	-1.96%	2.80%	3.15%	1.92%	2.28%	0.27%
FCF Margin	3.81%	5.05%	23.92%	-4.28%	6.04%	1.59%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Dividend Per Share Dividend Per Share Growth	0.360	0.360	0.350	0.285	0.033
Dividend Per Share Growth	-8.57%	2.86%	22.81%	763.64%	-
Dividend Yield	0.18%	0.21%	0.61%	0.50%	0.11%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	532.89	162.73	185.02	82.21	970.95
Forward PE	201.11	89.63	42.57	99.49	-	-
P/FCF Ratio	398.63	294.86	21.45	-	30.98	162.55
PS Ratio	15.20	14.90	5.13	3.54	1.87	2.59

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error